analyst downgrades

    By Melly Alazraki

    | 3:36PM 8/16/2010
    Several biotech stocks were on the move Monday after Deutsche Bank started rating them. The bank's analyst, Robyn Karnauskas, took a generally wary view on the biotech sector, putting buy ratings only on Gilead and Dendreon.

    By Melly Alazraki

    | 8:15AM 4/09/2010
    The following is a round-up of news likely to affect stock prices today: Citigroup (C), Goldman Sachs (GS), J.P. Morgan Chase (JPM), Morgan Stanley (MS) and Bank of America (BAC) are just five of 18 banks that masked the level of risk they took over the last five quarters by lowering their debt...